This Fact Sheet explains where and when PPI is possible and who should be involved. 

The GGOP defines common clinical-research standards used across the SCTO CTU Network to ensure participant safety, high-quality operations, and efficient use of academic resources.

This guide helps researchers identify meaningful opportunities to involve patients and the public in their studies.

These guidelines outline risk-based monitoring for clinical trials and help identify the appropriate monitoring risk category for each study.

This guidance document provides practical recommendations for fulfilling the regulatory requirements and safety reporting obligations applicable to Category A clinical trials on Investigational Medicinal Products (IMPs) in Switzerland.

harmBounds R Package calculates stopping probabilities, defines stopping boundaries, and produces plots for safety monitoring using a simple event-based approach. The package supports safety interim analyses during trial conduct. Further development toward a broader vignette on safety interim analyses is being considered.

This document provides a practical overview of key changes introduced in the revised HRA ordinances.

Practical guidance on observational study submission through the BASEC portal in line with HRO Chapter 2 and a further use project according to HRO Chapter 3.

This seminar session will provide an overview of the SPHN Federated Clinical Routine Dataset, a remarkable resource designed to give healthcare researchers access to vast amounts of patient data for further use research according to HRO chapter 3.

Essentials of data procurement, governance, and protection. The most important aspects regarding the new data protection law and practical insights into how data are handled at different university hospitals will be presented